Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.590
+0.620 (63.92%)
May 29, 2025, 3:00 PM EDT
Silence Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -71.53 | -45.31 | -54.23 | -50.33 | -53.36 | -44.44 | Upgrade
|
Depreciation & Amortization | 0.58 | 0.59 | 0.62 | 0.6 | 0.58 | 0.68 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | - | -0 | Upgrade
|
Stock-Based Compensation | 15.73 | 16.31 | 16.27 | 12.69 | 11.69 | 6 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | - | -6.64 | Upgrade
|
Other Operating Activities | -3.38 | -6.21 | 3.12 | -0.6 | -2.29 | 4.22 | Upgrade
|
Change in Accounts Receivable | 10.05 | -0.9 | 0.39 | -0.72 | 37.21 | -40.01 | Upgrade
|
Change in Accounts Payable | 5.2 | 0.5 | -0.47 | 2.02 | 3.26 | 1.78 | Upgrade
|
Change in Unearned Revenue | -23.34 | -28.79 | -10.32 | -5.44 | 11.33 | 68.79 | Upgrade
|
Change in Other Net Operating Assets | -4.11 | -3.83 | -4.84 | -15.26 | 0.8 | -5.09 | Upgrade
|
Operating Cash Flow | -70.81 | -67.64 | -49.46 | -57.04 | 9.22 | -14.71 | Upgrade
|
Capital Expenditures | -0.22 | -0.21 | -0.06 | -0.17 | -1.78 | -0.7 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | -0.37 | -0.03 | -0 | Upgrade
|
Investment in Securities | -16.22 | -21.76 | 19.35 | -19.95 | 13.54 | 13.65 | Upgrade
|
Other Investing Activities | - | - | - | - | 0.01 | 0.18 | Upgrade
|
Investing Cash Flow | -16.44 | -21.97 | 19.29 | -20.5 | 11.75 | 13.13 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -0.29 | -0.55 | Upgrade
|
Net Debt Issued (Repaid) | - | - | - | - | -0.29 | -0.55 | Upgrade
|
Issuance of Common Stock | 9.08 | 142.09 | 31.94 | 52.58 | 41.87 | 21.61 | Upgrade
|
Financing Cash Flow | 9.08 | 142.09 | 31.94 | 52.58 | 41.58 | 21.06 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.33 | 0.06 | 0.75 | -8.12 | -0.14 | -0.46 | Upgrade
|
Net Cash Flow | -77.84 | 52.54 | 2.52 | -33.08 | 62.41 | 19.02 | Upgrade
|
Free Cash Flow | -71.02 | -67.85 | -49.52 | -57.22 | 7.44 | -15.41 | Upgrade
|
Free Cash Flow Margin | -256.38% | -156.85% | -156.49% | -264.22% | 44.26% | -206.00% | Upgrade
|
Free Cash Flow Per Share | -1.51 | -1.47 | -1.33 | -1.78 | 0.25 | -0.56 | Upgrade
|
Cash Income Tax Paid | 0.68 | 0.43 | 0.8 | - | - | -4.12 | Upgrade
|
Levered Free Cash Flow | -24.17 | -25.37 | -23.31 | -26.84 | -6.72 | -46.6 | Upgrade
|
Unlevered Free Cash Flow | -24.17 | -25.37 | -23.31 | -26.84 | -6.71 | -46.58 | Upgrade
|
Change in Net Working Capital | -4.88 | 11.07 | 7.38 | 7.57 | -21.6 | 26.12 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.